Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Health care access domains and treatment as mediators of ovarian cancer racial disparities in survival: A structural equation modeling analysis in SEER-Medicare

  • Clare Meernik
  • , Quan Chen
  • , Lauren E. Wilson
  • , Ashwini Joshi
  • , Fariha Rahman
  • , Maria Pisu
  • , Margaret Liang
  • , Kevin C. Ward
  • , Margaret Gates Kuliszewski
  • , Thomas Tucker
  • , Andrew Berchuck
  • , Bin Huang
  • , Tomi Akinyemiju

Producción científica: Articlerevisión exhaustiva

Resumen

Racial differences in health care access (HCA) may contribute to disparities in ovarian cancer (OC) survival. We used structural equation models (SEMs) to examine associations between race and HCA domains (affordability, availability, accessibility) in relation to overall and OC-specific mortality. Non-Hispanic (NH)-Black and non-Black (Hispanic, NH-White) women diagnosed with OC in 2008-2015 were identified from Surveillance, Epidemiology, and End Results-Medicare. Cox proportional hazards regression was used to conduct mediation analysis for associations between race and HCA domains with overall and OC-specific mortality. SEM models adjusting for demographic and clinical covariates were used to estimate hazard ratios (HRs) and 95% CIs. A total of 4629 eligible patients with OC were identified, including 255 (5.5%) patients who were NH-Black. In SEM adjusting for demographic, clinical, and HCA latent variables, there was a total effect of NH-Black race on overall (HR, 1.11, 95% CI, 1.03-1.19) and OC-specific mortality (HR, 1.16; 95% CI, 1.08, 1.24), which was primarily driven by a direct effect. There was a modest indirect association between NH-Black race and mortality through decreased treatment receipt, though not through HCA. There is a need for studies investigating additional social and biological mechanisms that contribute to worse cancer survival among NH-Black patients. This article is part of a Special Collection on Gynecological Cancer.

Idioma originalEnglish
Páginas (desde-hasta)2230-2240
Número de páginas11
PublicaciónAmerican Journal of Epidemiology
Volumen194
N.º8
DOI
EstadoPublished - ago 1 2025

Nota bibliográfica

Publisher Copyright:
© 2024 The Author(s). All rights reserved.

Financiación

The authors acknowledge the helpful assistance provided by the SEER-Medicare reviewers, the Information Management System coordinator, and all patients whose valuable data contributed to this study. The collection of cancer incidence data used in this study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under cooperative agreement 1NU58DP007156; the National Cancer Institute’s SEER Program under contract HHSN261201800032I awarded to the University of California, San Francisco, contract HHSN261201800015I awarded to the University of Southern California, and contract HHSN261201800009I awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the author(s) and do not necessarily reflect the opinions of the State of California, Department of Public Health, the National Cancer Institute, and the CDC or their contractors and subcontractors. This research was funded by the National Institutes of Health/National Cancer Institute (Grant number R37CA233777; PI: Dr. Tomi Akinyemiju). The authors acknowledge the helpful assistance provided by the SEER-Medicare reviewers, the Information Management System coordinator, and all patients whose valuable data contributed to this study. The collection of cancer incidence data used in this study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries, under cooperative agreement 1NU58DP007156; the National Cancer Institute's SEER Program under contract HHSN261201800032I awarded to the University of California, San Francisco, contract HHSN261201800015I awarded to the University of Southern California, and contract HHSN261201800009I awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the author(s) and do not necessarily reflect the opinions of the State of California, Department of Public Health, the National Cancer Institute, and the CDC or their contractors and subcontractors.

FinanciadoresNúmero del financiador
University of Southern California
National Institutes of Health (NIH)
Georgia Department of Public Health
Centers for Disease Control and Prevention1NU58DP007156
National Childhood Cancer Registry – National Cancer InstituteHHSN261201800032I, R37CA233777

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Epidemiology

    Huella

    Profundice en los temas de investigación de 'Health care access domains and treatment as mediators of ovarian cancer racial disparities in survival: A structural equation modeling analysis in SEER-Medicare'. En conjunto forman una huella única.

    Citar esto